Puma Biotechnology Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Oncopeptides and Ascendis Pharma.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | ||
Founding Date | Founding Date 1981 | Founding Date 2000 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US |
Employees | Employees 277161% increase | Employees 80 | Employees 1,017 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 42.4 m | Valuation ($) 7.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) kr71.1m (FY, 2025) | Revenue (est.) €720.1m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods kr2.5m (FY, 2025) | Cost of goods €93.1m (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit kr72m (FY, 2025) | Gross profit €627.1m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (kr249.6m) (FY, 2025) | Net income (€228m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 56m | Total funding raised N/A | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company